ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Authorization Bill Passes Senate 82-0

June 27, 1980

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

Trials Approved by NCI CTEP For the Month of December

December 30, 2011

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

November 26, 2010